Change - Announcement Of Cessation Of Independent Non-Executive Director
|Announcement Title||Change - Announcement of Cessation|
|Date & Time of Broadcast||May 30, 2022 9:20|
|Announcement Sub Title||Cessation of Independent Non-Executive Director|
|Submitted By (Co./ Ind. Name)||Leow Quek Shiong and Gary Loh Weng Fatt|
|Description (Please provide a detailed description of the event in the box below)||This announcement has been prepared by the Judicial Managers for and on behalf of the Company and its contents have been reviewed by the Company's Sponsor, Hong Leong Finance Limited. It has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.
The contact person for the Sponsor is Mr Kaeson Chui, Vice President, at 16 Raffles Quay, #01-05 Hong Leong Building, Singapore 048581, Telephone (65) 6415 9886.
|Name Of Person||Hau Khee Wee|
|Is effective date of cessation known?||Yes|
|If yes, please provide the date||27/05/2022|
|Detailed Reason (s) for cessation||Mr Hau Khee Wee has resigned as Independent Non-Executive Director due to other new career opportunities.
Additionally, as the Company has been placed under Judicial Management on 4 May 2022, Mr Hau Khee Wee is of the view that he has no role to play remaining as a Director of the Company as the powers of the Directors are suspended while the Company is under Judicial Management.
After having interviewed Mr Hau Khee Wee and to best of its knowledge, the Sponsor is satisfied that there are no other material reasons for the cessation of Mr Hau Khee Wee as a Director of the Company.
|Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?||No|
|Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?||No|
|Any other relevant information to be provided to shareholders of the listed issuer?||No|
|Date of Appointment to current position||26/01/2022|
|Does the AC have a minimum of 3 members (taking into account this cessation)?||No|
|Number of Independent Directors currently resident in Singapore (taking into account this cessation)||1|
|Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months||4|
|Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)||Independent Non-Executive Director|
|Role and responsibilities||Fulfilling the roles and responsibilities of an Independent Non-Executive Director.|
|Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries||Nil|
|Shareholding interest in the listed issuer and its subsidiaries?||No|
|Past (for the last 5 years)||1. T.H.E. Fullerton Healthcare Group Limited
2. S.C. Fullerton Healthcare Group Limited
3. FHHK Aurum Limited
4. Health Maintenance Management Services Limited
5. HM Investment Holdings Limited
6. HMMP Dental Limited
7. Health Maintenance Medical Practice Limited
8. Dr Tony Chun Kit Lee Medical Practical Limited
9. Aurum Holdings
10. Washington Health Analytics Limited
11. HMMP Medical (Macau) Limited
12. Fullerton Health Clinic (HK) Holdings Limited
13. Keith Chan Musculoskeletal and Family Medicine Centre Co., Ltd
14. Fullerton Health Global Doctors Pte Ltd
15. Evive Biotechnology Singapore Pte Ltd
|Present||1. Scigen Pte Ltd
2. Scigen (Australia) Pty Ltd
3. China Kunda Technology Holdings Limited
4. Bioton S.A.
5. Evive Biotechnology Singapore Pte Ltd (Resigned on 21 October 2020, reappointed on 2 August 2021)
6. Imperium Crown Limited